• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医临床研究需要发展自己的核心结局集体系。

Clinical research of traditional chinese medicine needs to develop its own system of core outcome sets.

机构信息

Center for Evidence-Based Medicine, Tianjin University of Traditional Chinese Medicine, 312 Anshanxi Road, Nankai District, Tianjin 300193, China.

出版信息

Evid Based Complement Alternat Med. 2013;2013:202703. doi: 10.1155/2013/202703. Epub 2013 Nov 7.

DOI:10.1155/2013/202703
PMID:24312133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3838829/
Abstract

Currently, quality issues concerning clinical research of traditional Chinese medicine (TCM) have come into the spotlight. It has been recognized that poorly-devised research methodology largely restricted the development of clinical research in TCM. The choice of appropriate outcome measurements is key to the success of clinical research; however, the current procedure for outcomes selection in clinical research of TCM is problematic due to the underdevelopment of clinical methodology. Under this circumstance, we propose the introduction to the concept of Core Outcome Set (COS) and discuss the feasibility of developing a COS system that caters for clinical studies in TCM, in the hope that the outcome evaluation system could be up to international standards.

摘要

目前,中药(TCM)临床研究的质量问题已经引起了关注。人们认识到,研究方法设计不当在很大程度上限制了 TCM 临床研究的发展。选择合适的结局测量是临床研究成功的关键;然而,由于临床方法学的发展不足,目前 TCM 临床研究中结局选择的程序存在问题。在这种情况下,我们提出引入核心结局集(COS)的概念,并探讨开发适合 TCM 临床研究的 COS 系统的可行性,希望使结局评估系统达到国际标准。

相似文献

1
Clinical research of traditional chinese medicine needs to develop its own system of core outcome sets.中医临床研究需要发展自己的核心结局集体系。
Evid Based Complement Alternat Med. 2013;2013:202703. doi: 10.1155/2013/202703. Epub 2013 Nov 7.
2
Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.制定基于传统中医(COS-TCM)的慢性心力衰竭(CHF)核心结局集:研究方案。
BMJ Open. 2021 Jul 2;11(7):e047148. doi: 10.1136/bmjopen-2020-047148.
3
Development of a core outcome set in the clinical trials of traditional Chinese medicine for diabetic foot: A study protocol.糖尿病足中医临床试验核心结局集的制定:一项研究方案
Front Med (Lausanne). 2022 Nov 9;9:1025833. doi: 10.3389/fmed.2022.1025833. eCollection 2022.
4
Development of a Core Outcome Set in the Clinical Trials of Traditional Chinese Medicine for Stroke: A Study Protocol.中医药治疗中风临床试验核心结局集的制定:一项研究方案
Front Med (Lausanne). 2022 Mar 3;9:753138. doi: 10.3389/fmed.2022.753138. eCollection 2022.
5
Developing a Core Outcome Set for Assessing Clinical Safety Outcomes of Prostate Cancer in Clinical Trials of Traditional Chinese Medicine: Protocol for a Mixed Methods Study.制定用于评估中医药治疗前列腺癌临床试验临床安全性结局的核心结局集:一项混合方法研究方案
JMIR Res Protoc. 2023 Aug 7;12:e46794. doi: 10.2196/46794.
6
[Evidence-based Chinese medicine:theory and practice].[循证中医学:理论与实践]
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):1-7. doi: 10.19540/j.cnki.cjcmm.20171127.001.
7
Treatment of Chronic Pulmonary Heart Disease with Traditional Chinese Medicine: A Protocol for the Development of a Core Outcome Set (COS-TCM-CPHD).中医治疗慢性肺源性心脏病:核心结局集(COS-TCM-CPHD)的制定方案
Evid Based Complement Alternat Med. 2021 Apr 12;2021:5559883. doi: 10.1155/2021/5559883. eCollection 2021.
8
Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine.用于开发中西医结合临床试验核心结局集的方法。
J Integr Med. 2021 Sep;19(5):389-394. doi: 10.1016/j.joim.2021.07.001. Epub 2021 Jul 28.
9
[Exploration and consideration on establishing a core outcome set of Traditional Chinese Medicine clinical trials in distal radius fracture].[关于建立桡骨远端骨折中医临床试验核心结局集的探索与思考]
Zhongguo Gu Shang. 2023 Sep 25;36(9):901-4. doi: 10.12200/j.issn.1003-0034.2023.09.020.
10
[Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine].关于指导中药新药研发的理论思考
Zhongguo Zhong Yao Za Zhi. 2021 Apr;46(7):1686-1690. doi: 10.19540/j.cnki.cjcmm.20210213.501.

引用本文的文献

1
Outcomes reporting in clinical trials of Chinese herbal medicine on ulcerative colitis: A systematic review.中药治疗溃疡性结肠炎临床试验的结果报告:一项系统评价。
J Evid Based Med. 2024 Dec;17(4):691-695. doi: 10.1111/jebm.12649. Epub 2024 Oct 28.
2
Development of the Korean Medicine Core Outcome Set for Facial Palsy: herbal medicine treatment of patients with facial palsy in primary clinics.面瘫韩医学核心结局集的制定:基层诊所中面瘫患者的草药治疗
Front Med (Lausanne). 2024 May 22;11:1391544. doi: 10.3389/fmed.2024.1391544. eCollection 2024.
3
Analysis of clinical evidence on traditional Chinese medicine for the treatment of diabetic nephropathy: a comprehensive review with evidence mapping.分析中医药治疗糖尿病肾病的临床证据:基于证据图谱的综合评价
Front Endocrinol (Lausanne). 2024 Mar 27;15:1324782. doi: 10.3389/fendo.2024.1324782. eCollection 2024.
4
Effect of acupuncture therapy for postoperative gastrointestinal dysfunction in gastric and colorectal cancers: an umbrella review.针刺疗法对胃癌和结直肠癌术后胃肠功能障碍的影响:一项伞状综述
Front Oncol. 2024 Feb 5;14:1291524. doi: 10.3389/fonc.2024.1291524. eCollection 2024.
5
Development of CORE-CM core outcome domain sets for trials of Chinese medicine for lumbar spinal stenosis.制定针对中国医学治疗腰椎椎管狭窄症试验的 CORE-CM 核心结局域集。
BMJ Open. 2023 Oct 16;13(10):e075856. doi: 10.1136/bmjopen-2023-075856.
6
Development of a core outcome set on Traditional Chinese Medicine and for rheumatic heart disease: a study protocol.制定基于中医药治疗风湿性心脏病的核心结局集:研究方案。
BMJ Open. 2022 Nov 11;12(11):e062497. doi: 10.1136/bmjopen-2022-062497.
7
Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia.制定高脂血症中医临床试验的核心结局指标集。
Front Pharmacol. 2022 May 2;13:847101. doi: 10.3389/fphar.2022.847101. eCollection 2022.
8
Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.制定基于传统中医(COS-TCM)的慢性心力衰竭(CHF)核心结局集:研究方案。
BMJ Open. 2021 Jul 2;11(7):e047148. doi: 10.1136/bmjopen-2020-047148.
9
Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set.中药治疗高脂血症试验中的结果报告差异:制定核心结局集的系统评价
Evid Based Complement Alternat Med. 2021 Jun 10;2021:8822215. doi: 10.1155/2021/8822215. eCollection 2021.
10
The Use of Multiple Primary Outcomes in Randomized Controlled Trials of Chinese Herbal Medicine.中药随机对照试验中多个主要结局指标的应用
Evid Based Complement Alternat Med. 2021 Apr 21;2021:9975351. doi: 10.1155/2021/9975351. eCollection 2021.

本文引用的文献

1
Adaption and application of the four phase trials to traditional chinese medicines.四期临床试验在中药中的适应和应用。
Evid Based Complement Alternat Med. 2013;2013:128030. doi: 10.1155/2013/128030. Epub 2013 Aug 20.
2
Developing core outcome sets for clinical trials: issues to consider.制定临床试验核心结局集:需要考虑的问题。
Trials. 2012 Aug 6;13:132. doi: 10.1186/1745-6215-13-132.
3
Construction of a traditional Chinese medicine syndrome-specific outcome measure: the Kidney Deficiency Syndrome Questionnaire (KDSQ).构建中医证候特异性结局测量工具:肾虚证候问卷(KDSQ)。
BMC Complement Altern Med. 2012 Jun 6;12:73. doi: 10.1186/1472-6882-12-73.
4
The impact of Cochrane Reviews.考克兰系统评价的影响。
Cochrane Database Syst Rev. 2010 Jul 7;2011(7):ED000007. doi: 10.1002/14651858.ED000007.
5
Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine.中药不良反应/事件报告的建议。
J Evid Based Med. 2010 Feb;3(1):11-7. doi: 10.1111/j.1756-5391.2010.01056.x.
6
Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies.运用德尔菲技术确定临床试验的疗效指标:基于现有研究的系统评价对未来的建议
PLoS Med. 2011 Jan 25;8(1):e1000393. doi: 10.1371/journal.pmed.1000393.
7
Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany.特应性皮炎结局指标协调(HOME)。第一次国际共识会议(HOME1)报告,2010 年 7 月 24 日,德国慕尼黑。
Br J Dermatol. 2010 Dec;163(6):1166-8. doi: 10.1111/j.1365-2133.2010.10054.x.
8
Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management.非愈合伤口对照研究与比较研究的结果:提高伤口管理证据质量的建议。
J Wound Care. 2010 Jun;19(6):237-68. doi: 10.12968/jowc.2010.19.6.48471.
9
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.修订后的针刺临床试验干预报告标准(STRICTA):扩展 CONSORT 声明。
PLoS Med. 2010 Jun 8;7(6):e1000261. doi: 10.1371/journal.pmed.1000261.
10
Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review.用于中风后运动功能障碍的复方中药:一项系统评价。
Stroke. 2009 Aug;40(8):2797-804. doi: 10.1161/STROKEAHA.109.555227. Epub 2009 Jun 25.